This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
A forum of leading hepatologists, endocrinologists and clinical development experts stewarding advances in science, clinical research and therapeutics for nonalcoholic fatty liver disease and steatohepatitis
EVENTS
7th Metabolic Continuum Roundtable Annual Meeting – Steatotic Liver Disease (MASLD/MASH): Disease Burden - Patient Reported Outcomes - Health Economics: Payor & Societal Perspectives
November 10, 2023, Boston, MA
6th NASH Roundtable Forum – Clinical Trials with Non-Invasive Tests (NITs) Instead of Histology: Fact or Fancy?
More information »5th NASH Roundtable Virtual Forum – Is Digital Pathology a Game-Changer for Histology for NASH Drug Development?
More information »RESOURCES
Fact Sheet: NASH Roundtable™, leading clinical development experts addressing challenges in NASH drug development
View Fact Sheet »MEMBER CO-AUTHORED PUBLICATIONS
September 1, 2023
Nonalcoholic fatty liver disease (NAFLD) and associated mortality in individuals with type 2 diabetes, pre-diabetes, metabolically unhealthy, and metabolically healthy individuals in the United States Read More »
August 19, 2023
Progression of nonalcoholic fatty liver disease and long-term outcomes: A nationwide paired liver biopsy cohort study Read More »
August 7, 2023
Clinical care pathway to detect advanced liver disease in patients with type 2 diabetes through automated fibrosis score calculation and electronic reminder messages: a randomised controlled trial Read More »
August 3, 2023
Confirmatory biomarker diagnostic studies are not needed when transitioning from NAFLD to MASLD Read More »